Skip to content

Huisarts Roselien Leys

Active Private limited companyfounded 2024active for 2 yearsRuilare 127, 9080 LochristiKBO/BCE: BE 1014.730.757

Lifetime

2 annual accounts with figures on one time axis
peak of €120,472 in 2025
€120,472▲ 543%
peak of €85,155 in 2025
€85,155▲ 608%
peak of €97,513 in 2025
€97,513▲ 639%
€34,323▲ 25.7%
Board1 name since 2024
1 director
Documentsfilings and deeds
30-06-202631 days before the deadline
2025micro format
Gross margin from €18,740 to €120,472Result from €12,024 to €85,155Dividend €833Equity from €13,191 to €97,513Debts from €27,296 to €34,323Cash from €14,626 to €90,613

Key points

from the 2025 annual accounts

Equity

€97,513 ▲ 639%
13,1912024+85,155Profit-833Dividend97,5132025

Huisarts Roselien Leys paid out €833 in dividends. That is 1% of the 2025 profit.

Result

€85,155 ▲ 608%
€12,0002024€85,2002025

The result rose in 2025 from €12,024 to €85,155.

Liquidity

3.57 was 0.75 in 2024

Short-term debts rose from €27,296 to €34,323.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,327 companies had the same profile as Huisarts Roselien Leys has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 498,062 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,327 companies, not a prediction for Huisarts Roselien Leys. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 100 sharesdeed of 09-10-2024
Board & ownership

Recent changes

Incorporation Founding capital of €2,000, 100 shares · Founded by · appointed as director · published on 09-10-2024 · Gazette deed
First establishment Ruilare 127, Lochristi
All 5 events

Comparable companies

same main activity, similar in size and age
Company
Huisarts Roselien Leys Lochristi €131,836 €120,472 74.0% -
Dokter Loïck Vanwetter Gavere €129,914 €117,124 79.7% -
Dr. Pauline Van den Bossche Waasmunster €128,700 €112,845 68.7% -
Dr. Tali Rahoens Wetteren €136,570 €125,213 75.4% -
HUISARTS A. WEYNS Ghent €146,528 €113,289 82.7% -
HUISARTSPRAKTIJK VEERLE DEREWIANKA Denderleeuw €150,544 €115,970 84.1% -
DANIEL MAES HUISARTS Ghent €148,609 €113,513 69.5% -

These companies have the same main activity as Huisarts Roselien Leys: general medical practice (NACE 86210). They are comparable in size and age: total assets between €129,000 and €151,000, founded in 2024.

Official details

Source: KBO
Status
Active since 07-10-2024Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.364.682.6289080 Lochristi, since 07-10-2024
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €220,000estimated
€131,836▲ 226%
Filing
Filed on 30-06-2026, 31 days before the end of the filing period
Financials

Insights on Huisarts Roselien Leys

Huisarts Roselien Leys has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €97,513 and a net result of €85,155.

Its solvency ranks better than 62% of 21,385 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Huisarts Roselien Leys

What is the company number of Huisarts Roselien Leys?
The company number of Huisarts Roselien Leys is 1014.730.757. The VAT number is the same number with BE in front: BE 1014.730.757.
Where is Huisarts Roselien Leys based?
The registered office is at Ruilare 127, 9080 Lochristi.Company details
What does Huisarts Roselien Leys do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Huisarts Roselien Leys?
Huisarts Roselien Leys is a private limited company (BV).
When was Huisarts Roselien Leys founded?
Huisarts Roselien Leys was founded on 07-10-2024.
Is Huisarts Roselien Leys still active?
Yes, Huisarts Roselien Leys is an active enterprise in the KBO register.
What is the turnover of Huisarts Roselien Leys?
The turnover in financial year 2025 is about €220,000. This figure is estimated from the gross margin of €120,472 and 30 comparable companies (NACE 86210). It probably lies between €170,000 and €270,000.Financials
Is Huisarts Roselien Leys profitable?
In financial year 2025, Huisarts Roselien Leys made a profit of €85,155.
Where can I find the annual accounts of Huisarts Roselien Leys?
Huisarts Roselien Leys filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Huisarts Roselien Leys due?
Huisarts Roselien Leys must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.